GE HealthCare Technologies Inc. $GEHC Shares Acquired by National Bank of Canada FI

National Bank of Canada FI lifted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) by 133.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 899,693 shares of the company’s stock after buying an additional 514,007 shares during the period. National Bank of Canada FI owned approximately 0.20% of GE HealthCare Technologies worth $66,640,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently bought and sold shares of the business. Dodge & Cox raised its holdings in GE HealthCare Technologies by 42.1% in the 2nd quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock valued at $1,745,678,000 after acquiring an additional 6,982,441 shares during the last quarter. Norges Bank purchased a new stake in shares of GE HealthCare Technologies in the second quarter valued at approximately $468,120,000. Holocene Advisors LP grew its position in shares of GE HealthCare Technologies by 178.5% in the second quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock valued at $298,306,000 after purchasing an additional 2,581,522 shares in the last quarter. Menora Mivtachim Holdings LTD. acquired a new stake in shares of GE HealthCare Technologies in the second quarter valued at approximately $80,755,000. Finally, Balyasny Asset Management L.P. purchased a new position in GE HealthCare Technologies during the second quarter worth approximately $58,388,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have issued reports on GEHC shares. Barclays initiated coverage on GE HealthCare Technologies in a report on Monday, October 13th. They issued an “equal weight” rating and a $86.00 target price for the company. Citigroup boosted their price target on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the company a “neutral” rating in a research report on Thursday. Wells Fargo & Company cut their price objective on shares of GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a research report on Thursday, October 30th. Wall Street Zen downgraded shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. Finally, BTIG Research reissued a “buy” rating and issued a $87.00 price target on shares of GE HealthCare Technologies in a research note on Friday, November 21st. Six analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $87.09.

Get Our Latest Analysis on GE HealthCare Technologies

GE HealthCare Technologies Trading Down 2.4%

NASDAQ GEHC opened at $83.96 on Monday. The company has a debt-to-equity ratio of 0.83, a current ratio of 1.18 and a quick ratio of 0.95. The stock has a market capitalization of $38.25 billion, a P/E ratio of 17.35, a PEG ratio of 3.51 and a beta of 1.09. The firm’s 50-day moving average is $76.82 and its two-hundred day moving average is $75.02. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last released its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The business had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $5.07 billion. During the same period in the previous year, the firm earned $1.14 EPS. The business’s revenue was up 5.8% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, sell-side analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Friday, January 9th will be paid a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio is 2.89%.

GE HealthCare Technologies Profile

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

See Also

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.